CTCs
The firm cited new study results confirming that an assay analyzing circulating tumor cells isolated by its Parsortix platform can discriminate malignant pelvic masses.
4D Lifetec Raises $1.9M in Series B Financing to Support Lung Cancer Detection Test Launch
The company is hoping to accelerate its activities in Europe and is preparing to bring the cell-based test to the US by the end of next year.
Plus Therapeutics, Biocept Ink Lab Services Agreement for ReSPECT-LM Trial
Biocept will test patients with its CNSide cerebrospinal fluid cell capture assay to evaluate responses to Plus' radiotherapy drug candidate.
BioMark Diagnostics, Icahn Mount Sinai to Develop Multiomic Lung Cancer Tests
The partners also aim to develop a test for determining lung cancer subtype and stage using circulating tumor cells and metabolomics.
Genetron Highlights New Minimal Residual Disease Data, Sets Plans for Solid Tumor Testing in China
Premium
The company shared new liver cancer data in a recent journal letter, demonstrating high performance for its tumor-informed approach.
Aug 18, 2021
Mar 31, 2021
May 13, 2020
Biocept Q1 Revenues Up 41 Percent
Mar 16, 2020